Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June 30th 2012 Kelyniam Global Inc. reported a loss of $45,692...
-
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), today announced that the U.S. Food and Drug Administration (FDA) has granted the company authorization to market Custom...
-
Canton, CT, Sept. 27, 2012 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), today announced that the U.S. Food and Drug Administration (FDA) has granted the company authorization to market...
-
CANTON, Conn., June 20, 2012 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC:KLYG), a medical device company focused on the design and manufacturing of custom cranial implants, has filed a 510(k)...